TRINET GROUP, INC. Income Taxes Disclosure
| Year Ended December 31, | |||||||||||
| (in millions) | 2025 | 2024 | 2023 | ||||||||
| Current: | |||||||||||
Federal | $ | 11 | $ | 50 | $ | 96 | |||||
State | 5 | 4 | 24 | ||||||||
| Foreign | 2 | — | 2 | ||||||||
| Total Current | 18 | 54 | 122 | ||||||||
| Deferred: | |||||||||||
Federal | 40 | (2) | 1 | ||||||||
State | 3 | 1 | 3 | ||||||||
| Foreign | 1 | — | — | ||||||||
| Total Deferred | 44 | (1) | 4 | ||||||||
| Total | $ | 62 | $ | 53 | $ | 126 | |||||
| Year Ended December 31, | |||||||||||
| (in millions) | 2025 | 2024 | 2023 | ||||||||
| Federal | $ | 23 | $ | 64 | $ | 90 | |||||
| State: | |||||||||||
| California | (1) | * | * | ||||||||
| New York State | * | 4 | 6 | ||||||||
| Other | 3 | 6 | 18 | ||||||||
| Total State | 2 | 10 | 24 | ||||||||
| Foreign: | |||||||||||
| Canada | 1 | * | * | ||||||||
| India | 1 | * | * | ||||||||
| Total Foreign | 2 | 2 | — | ||||||||
| Total | $ | 27 | $ | 76 | $ | 114 | |||||
| Year Ended December 31, | ||||||||||||||||||||
| 2025 | 2024 | 2023 | ||||||||||||||||||
| (in millions, except percent) | Tax Expense/(Benefit) | Percent of Pre-Tax Income (Loss) | Tax Expense/(Benefit) | Percent of Pre-Tax Income (Loss) | Tax Expense/(Benefit) | Percent of Pre-Tax Income (Loss) | ||||||||||||||
| U.S. federal statutory tax rate | $ | 45 | 21 | % | $ | 48 | 21 | % | $ | 105 | 21 | % | ||||||||
State and local, net of federal income tax effect (1) | 7 | 3 | 4 | 2 | 23 | 5 | ||||||||||||||
| Foreign tax effects | 1 | — | — | — | — | — | ||||||||||||||
| Effect of cross-border tax laws | 1 | 1 | — | — | — | — | ||||||||||||||
| Tax credits: | ||||||||||||||||||||
| Research and development tax credits | (3) | (1) | (6) | (3) | (5) | (1) | ||||||||||||||
| Other | (1) | — | (1) | — | — | — | ||||||||||||||
| Changes in valuation allowances | 9 | 4 | — | — | — | |||||||||||||||
| Nontaxable or nondeductible items: | ||||||||||||||||||||
| Nondeductible compensation | 3 | 1 | 5 | 2 | 4 | 1 | ||||||||||||||
| Share-based payment awards | 3 | 1 | (1) | — | (4) | (1) | ||||||||||||||
| Other | 4 | 2 | 2 | 1 | 2 | — | ||||||||||||||
| Changes in unrecognized tax benefit | — | — | 1 | — | — | — | ||||||||||||||
| Other adjustments: | ||||||||||||||||||||
| Capital loss | (7) | (3) | — | — | — | — | ||||||||||||||
| Other | — | — | 1 | — | 1 | — | ||||||||||||||
| Total | $ | 62 | 29 | % | $ | 53 | 23 | % | $ | 126 | 25 | % | ||||||||
| Year Ended December 31, | ||||||||
| (in millions) | 2025 | 2024 | ||||||
| Deferred tax assets: | ||||||||
| Net operating losses (federal and state) | $ | 8 | $ | 5 | ||||
| Accrued expenses | 15 | 15 | ||||||
| Accrued workers' compensation costs | 9 | 9 | ||||||
| Operating lease liabilities | 12 | 9 | ||||||
| Stock based compensation | 3 | 2 | ||||||
| Tax benefits relating to uncertain positions | — | 1 | ||||||
| Tax credits (federal, state and foreign) | 7 | 8 | ||||||
| Section 174 Capitalized R&D | 3 | 18 | ||||||
| Other | 14 | 3 | ||||||
| Total | 71 | 70 | ||||||
| Valuation allowance | (18) | (8) | ||||||
| Total deferred tax assets | 53 | 62 | ||||||
| Deferred tax liabilities: | ||||||||
| Depreciation and amortization | (71) | (35) | ||||||
| Prepaid commission expenses | (26) | (28) | ||||||
| Operating lease right-of-use assets | (8) | (5) | ||||||
| Total deferred tax liabilities | (105) | (68) | ||||||
| Net deferred tax liabilities | $ | (52) | $ | (6) | ||||
| Year Ended December 31, | |||||||||||
| (in millions) | 2025 | 2024 | 2023 | ||||||||
| Valuation allowance at January 1 | $ | 8 | $ | 8 | $ | 8 | |||||
| Charged to net income | 10 | — | — | ||||||||
| Valuation allowance at December 31 | 18 | 8 | 8 | ||||||||
| Year Ended December 31, | |||||||||||
| (in millions) | 2025 | 2024 | 2023 | ||||||||
| Unrecognized tax benefits at January 1 | $ | 8 | $ | 7 | $ | 7 | |||||
Additions for tax positions of prior periods | — | 1 | — | ||||||||
Additions for tax positions of current period | 3 | 2 | 2 | ||||||||
Reductions for tax positions of prior period: | |||||||||||
Lapse of applicable statute of limitations | (2) | (2) | (2) | ||||||||
| Unrecognized tax benefits at December 31 | $ | 9 | $ | 8 | $ | 7 | |||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 12, 2026 | Showing above |
| 2021 | Feb 14, 2022 | |
| 2020 | Feb 16, 2021 | |
| 2019 | Feb 13, 2020 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.